Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: ketoconazole route-specific product safety
Also known as: Ketoconazole powder
Ketoconazole is an antifungal agent FDA-approved (topical formulations) for seborrheic dermatitis and dandruff, but is separately studied and used off-label in androgenetic alopecia (AGA) research and treatment. Evidence supports that topical ketoconazole 2% shampoo locally disrupts the DHT (dihydrotestosterone) pathway, likely via local 5-alpha-reductase inhibition - the same pathway targeted by finasteride, but via topical, localized action. A published study evaluated ketoconazole as an adjunct to finasteride in AGA treatment, and mouse studies found topical ketoconazole promoted hair growth alone and in combination with minoxidil. In this catalog's research context, ketoconazole's hair-loss application (not its antifungal indication) is the relevant use case, and it is frequently studied/formulated alongside minoxidil and latanoprost for AGA.
Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.
Data source: Current U.S. tablet and shampoo prescribing information
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Amounts and schedules are separated by administration route. Evidence badges distinguish labels, human studies, preclinical work, community reports, and evidence gaps.
Apply 2% shampoo to affected skin once and leave for 5 minutes before rinsing for tinea versicolor
Context: current DailyMed shampoo label
Formulation: Concentration, vehicle, treated area, and product sterility are formulation-specific.
Route safety: Use only in the cited label or guideline context; route, formulation, indication, and patient-specific limits still apply.
Oral dosing is reserved for selected serious systemic mycoses when alternatives are unavailable
Context: boxed-warning tablet label
Formulation: Oral-mucosal formulations are not dose-equivalent to injectable or topical formulations.
Route safety: Research-study protocol only; it is not an approved or individualized instruction and should not be extrapolated to another route.
Do not convert an amount between routes. Bioavailability, formulation, sterility, monitoring, and clinical context differ by route. Research-use context only; independently verify every cited source.
Reflects patterns reported in research/community literature only. Not a safety guarantee, medical advice, or interaction warning for human use.
The row is a marketed antifungal drug and must distinguish topical from oral risk. Oral ketoconazole is not indicated for common superficial fungal infections when safer alternatives exist.
Supplementary research context only. Not medical advice or a treatment recommendation.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.